Merel J l'Ami (Merel J L'ami)

Publication Activity (10 Years)

Years Active: 2019-2020
Publications (10 Years): 5

Top Topics

Randomized Controlled Trial

Systemic Lupus Erythematosus

Rheumatoid Arthritis

Disease Activity

Top Venues

Annals of the rheumatic diseases

JMIR research protocols

Science translational medicine

JMIR formative research

This page only lists publications with an associated author ORCID identifier.

Publications

Lea C Berkhout, Merel J l'Ami, Jill Ruwaard, Margreet H Hart, Pleuni Ooijevaar-de Heer, Karien Bloem, Michael T Nurmohamed, Ronald F van Vollenhoven, Maarten Boers, Daniel F Alvarez, Catherine H Smith, Gerrit J Wolbink, Theo Rispens
Dynamics of circulating TNF during adalimumab treatment using a drug-tolerant TNF assay. Science translational medicine 11 (477) (2020)
Bart F Seppen, Jimmy Wiegel, Merel J l'Ami, Sharon Duarte Dos Santos Rico, Fabio S Catarinella, Franktien Turkstra, Maarten Boers, Wouter H Bos
Feasibility of Self-Monitoring Rheumatoid Arthritis With a Smartphone App: Results of Two Mixed-Methods Pilot Studies. JMIR formative research 4 (9) (2020)
Bart F Seppen, Merel J l'Ami, Sharon Duarte Dos Santos Rico, Marieke M Ter Wee, Franktien Turkstra, Leo D Roorda, Fabio S Catarinella, Dirkjan van Schaardenburg, Michael T Nurmohamed, Maarten Boers, Wouter H Bos
A Smartphone App for Self-Monitoring of Rheumatoid Arthritis Disease Activity to Assist Patient-Initiated Care: Protocol for a Randomized Controlled Trial. JMIR research protocols 9 (2) (2020)
Lea C Berkhout, Merel J l'Ami, Gerrit Jan Wolbink, Theo Rispens
Comment on 'Sustained discontinuation of infliximab with a raising-dose strategy after obtaining remission in patients with rheumatoid arthritis: the RRRR study, a randomised controlled trial' by Tanaka et al. Annals of the rheumatic diseases 80 (11) (2019)
Merel J l'Ami, Charlotte L Krieckaert, Michael T Nurmohamed, Ronald F van Vollenhoven, Theo Rispens, Maarten Boers, Gerrit Jan Wolbink
Response to: 'Tapering without relapse in rheumatoid arthritis patients with high TNF blocker concentrations: data from the STRASS study' by Marotte et al. Annals of the rheumatic diseases 79 (7) (2019)